Lv61
2220 积分 2023-08-02 加入
Safety of Factor XI Inhibition With Abelacimab in Atrial Fibrillation by Kidney Function
17天前
已完结
Abelacimab Versus Rivaroxaban in Patients With Atrial Fibrillation Receiving Oral Antiplatelet Therapy: Definitely Safe, but How Effective?
1个月前
已完结
Factor XI inhibitors for the prevention and treatment of venous and arterial thromboembolism
1个月前
已完结
Long-Acting Factor XI Inhibition and Periprocedural Bleeding
1个月前
已关闭
Effect of heparins, DOACs, and FXII/FXI inhibitors on catheter-initiated thrombin generation in PRP: an in vitro study
1个月前
已关闭
EFFECTS OF MILVEXIAN ALONE OR WITH HEPARIN ON CATHETER-INDUCED CLOTTING AND THROMBIN GENERATION
2个月前
已关闭
Joint Associations of APOC3 and LDL-C–Lowering Variants With the Risk of Coronary Heart Disease
3个月前
已完结
Coagulation factor XI regulates endothelial cell permeability and barrier function in vitro and in vivo
3个月前
已完结
Long-Acting Factor XI Inhibition and Periprocedural Bleeding: An Analysis From AZALEA-TIMI 71
3个月前
已关闭
Factor XI/XIa inhibitors versus direct oral anticoagulants in atrial fibrillation with stroke risk: a GRADE-assessed meta-analysis of randomized controlled trials
3个月前
已完结
皖公网安备34019202002308
